InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（12 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
12
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Keyes Jason A, 首席财务官. Director active across 3 companies, notably Equillium, Inc.. In total, 19 disclosures have been recorded. Split: 1 buy · 12 sells. Total volume traded: €239k. Activity tracked since 26 May 2021. The latest transaction was disclosed on 10 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Keyes Jason A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
700 股@ US$16.00Common StockSEC:0001678152-26-000003:0
标准退出：2026年11月8日 (T+90)
10,000 股@ US$0.651.4% 占其流量Common StockSEC:0001415889-25-002070:0
15,000 股@ US$0.541.7% 占其流量Common StockSEC:0001415889-25-000843:0
10,000 股@ US$0.701.5% 占其流量Common StockSEC:0001415889-24-026987:0
10,000 股@ US$0.811.6% 占其流量Common StockSEC:0001415889-24-024079:0
10,000 股@ US$0.871.8% 占其流量Common StockSEC:0001415889-24-019776:0
15,000 股@ US$0.561.8% 占其流量Common StockSEC:0001209191-24-000515:0
4,444 股@ US$1.191.1% 占其流量Common StockSEC:0001209191-23-001367:0
7,000 股@ US$2.834.5% 占其流量Common StockSEC:0001209191-22-048037:0
40,000 股0Common StockSEC:0001485003-22-000082:0
5,000 股@ US$2.520.0086% mcap3.2% 占其流量Common StockSEC:0001209191-22-034749:0
8,000 股@ US$3.189.5% 占其流量Common StockSEC:0001209191-22-023220:0
5,585 股@ US$2.354.7% 占其流量Common StockSEC:0001209191-21-069177:0
5,000 股@ US$5.08039.2% 占其流量Common StockSEC:0001209191-21-067752:0
8,000 股@ US$6.740518.8% 占其流量Common StockSEC:0001209191-21-058029:0
5,000 股@ US$5.7179.9% 占其流量Common StockSEC:0001209191-21-048405:0
5,535 股@ US$2.354.4% 占其流量Common stock, par value $0.0001 per shareSEC:0001209191-21-040314:0
5,000 股@ US$6.49679.8% 占其流量Common StockSEC:0001209191-21-036648:0
5,000 股@ US$6.49679.8% 占其流量Common StockSEC:0001209191-21-036674:0
19 条申报中的 19 条
About Keyes Jason A
Keyes Jason A is Chief Financial Officer and has filed 18 disclosures in total. In the 18 sampled filings, all transactions are sales, for a total of EUR 228824, between 2021-05-28 and 2025-01-24. He is linked to Equillium, Inc. as Chief Financial Officer and to Sesen Bio, Inc. as Director.
